Company Search:
Advanced Search
Sponsored Links
IXICO PLC Company Snapshot
IXICO PLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares IXICO PLC with three other companies in this sector in the United Kingdom: Genedrive PLC (2017 sales of £5.79 million [US$8.08 million] of which 45% was Diagnostics Segment), Avacta Group Plc (£2.74 million [US$3.82 million] of which 58% was Animal Health), and Fusion Antibodies PLC (£1.91 million [US$2.67 million] of which 100% was Pharmaceutical).

Sales Analysis. IXICO PLC reported sales of £4.11 million (US$5.74 million) for the fiscal year ending September of 2017. This represents an increase of 32.1% versus 2016, when the company's sales were £3.11 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for IXICO PLC
  Stock Data: Recent Stock Performance:
  Current Price (3/9/2018): 36.50p
(Figures in Pounds Sterling)
1 Week 0.0%   13 Weeks -5.2%  
4 Weeks 23.7%   52 Weeks 24.8%  
  Ticker: IXI Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 4,110,000
(Year Ending Jan 2018).
Employees: 61
  Currency: Pounds Sterling Market Cap: 9,898,482
  Fiscal Yr Ends: September Shares Outstanding: 27,119,130
  Share Type: Ordinary Closely Held Shares: 6,180,089
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.